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ABSTRACT 
Kinase Suppressor of Ras 1 (KSR1) is an evolutionally 
conserved protein kinase that plays a fundamental role in 
mitogenic pathway. In response to Ras activation, KSR1 
assembles a tripartite kinase complex that optimally transfers 
signals generated at cell membrane to downstream ERK 
signaling. The role of KSR1 in Ras signaling has been largely 
explored. However, the impact of attenuating signals on KSR1 
was still elusive. Here, I contributed to identify a novel 
mechanism of ERK attenuation based on the ubiquitin-
dependent control of KSR1. Stimulation of membrane receptors 
by growth factor induced a rapid poly-ubiquitination of KSR1, 
which paralleled the decay of ERK signaling. We identified praja2 
as the principal E3 ligase that ubiquitinates KSR1. Interfering with 
praja2 expression or activity impeded KSR1 ubiquitination and 
sustained ERK signaling. 
Thus, the dynamic interplay between the ubiquitin system 
and scaffold components of the Ras pathway contributes to 
shape the profile of ERK signaling, profoundly impacting on 
fundamental aspects of cell behavior. 
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1.1. Mitogen-Activated Protein Kinases (MAPK) 
pathway and their scaffold proteins 
Several responses to hormones, or any extracellular stimulus, are 
transmitted to various intracellular targets through a series of 
protein networks that regulate and govern many cellular 
processes. The extracellular ligands interact with receptors on the 
cell membrane, which in turn activate the intracellular second 
messengers, thus initiating a cascade of signal transduction 
towards several target proteins.  Among the repertoire of the 
cascades of signaling molecules there is a family of protein kinase 
known as mitogen-activated protein (MAP) kinase. All these 
cascades must contain at least three protein kinases in series that 
culminate in the activation of a multifunctional MAP kinase (Lewis 
TS.  1998). MAP kinases are the main components of the pathways 
that control embryogenesis, differentiation, proliferation, and cell 
death. The mammalian MAP kinases consist of a cytoplasmic 
protein serine\treonine kinases that include the extracellular 
signal-regulated kinase (ERK) family, the p 38 family, the c-Jun N-
terminal kinase family. 
Each MAP kinase is  
regulated by a phosphorylation cascade that starts with a MAPK 
kinase kinase (MAP3K) that phosphorylates and activates a MAPK 
kinase (MAP2K).  MAPK kinase (MAP2K) phosphorylates and 
activates causing the phosphorylation of several downstream 
substrates such as transcription factors and other functional 
proteins. In ERK1\2 pathway these kinases are called Raf, MEK, 
and ERK (Figure 1); 
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Figure 1.MAPK specificity Diverse extracellular inputs active the 
Ras/Raf/MEK/ERK cascade and each can give a different cellular 
outcome 
 
 
The amplitude and the attenuation of the signal stimulated by 
MAP kinases are tighty regulated. In particular, the cascade of 
phosphorylation of the ERK1/2 pathway is amplified at the step of 
RAF phosphorylation on MEK, because MEK is about 100 times 
more abundant than the other two kinases (RAF and ERK) (Huang 
C-YF.  1996; Ferrell Jr JE. 1996 ).     
This pathway is activated by protein tyrosine kinase receptors, 
like EGF receptor (EGFR) or VEGF receptor (VEGFR) (Pearson G,; 
2001). In response to the ligand stimulus, the receptors dimerize, 
inducing trans-phosphorylation by intrinsic tyrosine kinases. This 
event leads to the recruitment ofsome proteins and to the 
activation of Ras. Ras is a GTPase, which hydrolyses guanosine 
triphosphate (GTP) to guanosine diphosphate (GDP). Active GTP-
Ras , kicks off to the signal. There are three Ras isoforms in 
mammals, namely H-Ras, K-Ras and N-Ras and it has been shown 
that mutations in the Ras gene are found in about 30% of human 
cancers, such as melanoma and biliary cancer (Vakiani E. et al.  
2011). 
Ras activates Raf kinase, recruiting it to the membrane. There 
are three known isoforms of Raf, called A-Raf, B-Raf and C-Raf 
(also known as Raf-1), each of them has distinct functions 
 
 
10 
 
(Wellbrock C.  2004). Each isoform contains three conserved 
regions, termed CR1, CR2, and CR3, where it is located the kinase 
domain. In turn, Raf becomes active and catalyses 
phosphorylation and activation of MEK1 and MEK2, which in turn 
activate ERK1/2.These are ubiquitous protein kinases of a 44 and 
42 kDa, respectively. ERK1 and ERK2 have 85% of identity, 
especially in the region involved in binding substrates (Boulton 
TG,; 1991).Nevertheless, some studies have shown that functions 
of the two isoforms are different. Indeed mice ERK2 - \ - are not 
viable (Yao Y. et al;. 2003), while mice ERK1-\- seem to have only a 
defect in the maturation of CD4+ and CD8+ cells (Pagès G. et al; 
1999),. Once activated, ERKs dimerize and translocate to the 
nucleus, where they phosphorylate transcription factors, or 
remain in the cytosol where they phosphorylate substrates in 
multiple cellular compartments(Matthew D. Brown; 2009) (Figure 
2) 
Since Raf can translocate to the plasma membrane 
Raf\MEK\ERK pathway may be also activated by some stimuli such 
as Src and PKC kinases, and by GPCR activation. It is shown that 
isoproterenol (a drug that acting through a GPCR, increases the 
intracellular level of cyclic AMP) treatment is able to increase the 
level of the active form of ERK in human embryonic kidney cells 
(Daaka Y,; 1997  Copik AJ1,; 2015). 
Instead, the effects caused by cAMP-dependent protein kinase 
A (PKA) are disputable , because some evidence indicate that PKA 
reduces Raf-1 activity (Wu J et al. 1993;  Hafner S. et al.  1994;  
Kikuchi A. et al. 1996;  Mischak H. et al. 1996). On the other hand, 
studies in neuronal cells demonstrated that PKA phosphorylates 
Rap1a, which increases ERK phosphorylation, through activation of 
B-Raf (Vossler MR. et al.  1997 - Grewal SS. et al.  2000). 
Temporal modulation of ERK cascade arouses distinct cellular 
responses(Murphy LO et al.  2006). In pheocromocytoma cells 
(PC12), different responses are observed after different stimuli 
that activate the same MEK/ERK pathway.PC12 cells proliferate in 
response to EGF, while nerve growth factor (NGF) induces 
differentiation (York RD1 1998). Further investigation has shown 
that EGF-dependent MAPK signaling is transient, lasting minutes 
from activation, while NGF-dependent signaling is sustained for 
hours from stimulation(Marshall CJ1 1995).  
So, who regulates the signal duration and intensity? And also, 
which upstream stimulus leads to the activation of every specific 
downstream signal? 
The mechanisms that regulate these phenomena have been 
unknown for long time. Presently, there are some evidences that 
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the scaffold proteins may be the answers to these questions. The 
presence of scaffold proteins as relevant components of MAPK 
pathway was studied firstly in the yeast S.Ceervisiae, where 
mutations in Ste5, a protein involved in the three-MAPK cascade 
assembly , destroyed the response to pheromone (Choi et al.1994;  
Marcus et al. 1994). There are evidences that also in mammalian 
MEK\ERK MAPK pathway the scaffold proteins have an important 
role for the correct activation, the signal propagation and turn off 
of the cascade. Moreover, scaffold proteins regulate and 
compartmentalize the signal diffusion to a specific subcellular 
location (Roskoski,2012). Scaffolds are thought to minimize 
crosstalk with other signaling cascades (Dhanasekaran et al. 
2007)and similarly mediate crosstalk of different pathways 
(Kolch,2005) and protect kinases from phosphatases action 
(Perlson et al. 2006). 
In the last years, different mammalian scaffold proteins have 
been isolated and characterized: KSR1 and KSR2, β-arrestin, paxilin 
MP1, MORG1, Sef and IQGAP1, but are located in different cellular 
districts, and so, they direct the signal amplification on different 
cellular compartments. In this context, KSR1/2 binds the kinases in 
the cytosol, β-arrestin in clathrin vesicles, MP1 active complex in 
late endosomes and Sef locates the kinase complex in the Golgi 
apparatus. Thus, different stimuli can activate a complex 
formation with a different scaffold protein. When the stimulus 
starts from an activated GPCR and is directed to early endosomes, 
β-arrestin captures the kinases and compartmentalizes  there the 
signal (Figure 2). 
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Figure 2. Spatial regulation of MEK/ERK signaling by protein scaffolds. 
Scaffolds can regulate the subcellular distribution MAPK proteins. Both IQGAP1 
and KSR bind to Raf, MEK and ERK and localize the kinases to the plasma 
membrane, while MP-1localizes the kinase complex to endosomes. After 
activation, ERK phosphorylates the downstream targets, or translocate to the 
nucleus and activate nuclear targets. KSR binds ERK dimers and restricts them 
to cytosolic targets. Like MP-1, β-arrestins localize Raf, MEK and ERK to 
endosomes. However, once activated, ERK cannot translocate to the nucleus 
and phosphorylates mostly cytosolic targets by an unknown mechanism. Sef 
restricts MEK and ERK to the Golgi and, like β-arrestin, prevents translocation of 
ERK to the nucleus, limiting it to cytosolic substrates. GPCR, G-protein coupled 
receptor; RTK, receptor tyrosine kinase. 
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1.2  Kinase Suppressor of Ras1 (KSR1) 
The KSR family proteins consist of two members namely KSR1 
and KSR2. They are widely conserved from invertebrate to 
mammals and the similarity of amino acids between them is 
approximately 60%.The structure of these proteins consists of 5 
domains called CA1-CA5.The CA1 domain is located in the N-
terminus and it is involved in the formation of a KSR1-MEK-RAF 
complex; it comprises 40 amino acids which are exclusive to KSR1, 
but absent from KSR2; CA2 is a proline-rich domain with unknown 
function; CA3 is a cysteine rich domain, needful for membrane 
recruitment by phospholipids (Michaud N.R. 1997); CA4 is a 
serine/threonine-rich region containing an FXFP (Phe-Xaa-Phe–
Pro) motif that is an ERK docking-site (Kolch W. 2005) and CA5 is 
highly homologous to the kinase domain of RAF proteins (see 
Figure 3)  and, for this reason, it is considered a putative kinase 
domain which lacks the conserved lysine residue, required for 
phosphorylation(Kolch W. 2005) (Figure 3). Furthermore a new 
domain of KSR1 composed by a coiled-coil (CC) and a sterile 
α(SAM)motifs, thus called CC-SAM, has been recently 
characterized. This domain targets KSR-1 in response to growth 
factor at the plasma membrane, and binds directly to various 
micelles and bicelles in vitro. (Koveal  D.  2012).  
 
 
 
 
Figure 3. KSR structure.KSR is composed by 5 domains called CA1-CA5. The CA1 
domain is responsible of the formation of a KSR1-MEK-RAF complex; CA2 is a 
proline-rich domain with unknown function; CA3 is a cysteine rich domain, 
needful for membrane recruitment with phospholipids; CA4 is a 
serine/threonine-rich region containing an FXFP (Phe-Xaa-Phe–Pro) motif that is 
an ERK docking-site and CA5 is a putative kinase domain in which the conserved 
lysine residue. 
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KSR1 and KRS2 were initially characterized as scaffold proteins  
involved in different pathways. KSR2 has several functions; it 
contains a region of 63 amino acids between the portion C3-C4, 
which is a specific region for binding AMPK and calcineurin. 
Calcineurin, when activated by intracellular calcium, binds KSR2 
and activates ERK signaling (Costanzo-Garvey DL. 2009 ; Dougherty 
MK. 2009). KSR2 gains an important function in energy 
metabolism regulation, as KSR2 knockout mice show an obese 
phenotype(Brommage R.  2008). 
On the other hand, KSR1 is recruited in the Ras/Raf/MAPK 
signaling cascade. In un-stimulated cells, C-TAK1 (Cdc25C-
associated kinase 1) phosphorylates KSR1 at Ser392. Hence, KSR1 
is sequestrated in the cytosol, where it constitutively interacts 
with MEK and ERK. Upon growth factor stimulation, Ras is 
activated and triggers dephosphorylation of KSR1 at Ser392 by 
PP2A (protein phosphatase 2A). After that, KSR1 shifts to the cell 
membrane, where it forms a complex with Raf, MEK and ERK.KSR1 
thus potentially makes easy the phosphorylation of Raf, MEK and 
ERK, facilitating the MAPK signaling, as well as the 
phosphorylation of multiple substrates in the cytoplasm and 
nucleus. Through this way, KSR1 regulates proliferation, cell cycle 
and apoptosis(Muller j.  2001;  Roy F. 2002;  Ory S. 2003)(Figure 4).  
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Figure 4. KSR1 regulation in thel Ras/Raf/MAPK pathway. In resting 
conditions,KSR1 is sequestered in the cytosol through 14-3-3 protein binding, 
after phosphorylation by C-TAK1 at Ser297 and Ser392. Meantime, KSR1 
constitutively interacts with MEK and ERK. Under stimulated conditions, it  
activates Ras that triggers dephosphorylation of KSR1 at Ser392 by PP2A, 
leading to the release of 14-3-3 protein from its binding sites.KSR1switches to 
the cell membrane, where it forms a complex with Raf, MEK and ERK, and 
promotes phosphorylation of downstream substrates.  
 
 
However, different groups found conflicting results on the role 
of KSR in the regulation of MAPK. Denouel-Galy showed that the 
MEK subpopulation complexed with exogenous KSR1in COS-1 cells 
or PC12 cells have no kinase activity because KSR1 blocks MEK in 
an inactive form. This block has a surprising biological effect: KSR1 
did not transform NIH3T3 cells, and, furthermore, reduced Ras-
induced transformation. Similarly, KSR1 inhibited the proliferation 
of embryonic neuroretinal cells induced by Ras (Denouel-Galy, A.  
1998).  
Protein scaffolds must be expressed in the cell at certain levels. 
Indeed, KSR1 may have different effects in the regulation of MAPK 
signaling according to its intracellular concentration. In fact, KSR1 
at low concentrations can increase the Ras downstream signaling, 
while high levels of KSR1have inhibitory effects on Ras pathway 
(Cacace AM. ; 1999). 
KSR1 is also an important regulator of the immune response. 
Thus, KSR1 plays a role in the protection from the inflammation, 
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bacterial infections, and in T cells proliferation. KSR1-/- are more 
susceptible to the manifestation of colitis induced by TNF alpha 
(Yan, F. 2004; Yan, F. 2001) and to infection by Pseudomonas 
aeruginosa (Zhang, Y.   2011). Perhaps, this was a consequence 
ofKSR1-mediated cytotoxic response of natural killer cells. 
Furthermore, in these mice the attenuation of the ERK pathway 
also causes a reduction of T-cell proliferation (Nguyen, A.  2002). 
However, KSR1 has not only the role of scaffold protein. KSR1 has 
been classified as inactive pseudo-kinase.However,in vitro studies 
have shown that KSR1 owns a real kinase activity and it is capable 
both of auto-phosphorylation and of MEK 
phosphorylation(Goettel, J.A. 2011). Furthermore, KSR1 
phosphorylates other substrates, even if not bound to MEK (Xing, 
H.R.  2004).In addition, KSR1 is able to regulate the temporal 
duration of the signal. McKay and collaborators demonstrated that 
KSR1 is subjected to phosphorylation and inhibition by activated 
ERK. In this circumstances, the scaffold is temporally inactivated 
and the multikinase complex is disassembled(McKay, M. et al. 
2009) (Figure 5). 
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Figure 5.KSR1 regulates the intensity and duration of ERK cascade. In resting 
cells, KSR1 binds MEK and keeps it away from Raf (A). In stimulated cells, KSR1 
facilitates the Raf/MEK interaction and first increases the signal transmission (B) 
and then attenuates the signal. Active ERK, in fact, can phosphorylate KSR1 
facilitating the disruption of the KSR1 scaffold complex  (CandD). 
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1.3  The ubiquitin proteasome system 
The amount of protein within the cell is usually kept constant 
or varied according to the needs of the latter. Dysregulation in the 
amount of specific proteins can lead to the development of 
diseases or disorders, including cancer. The balance between the 
synthesis and degradation of proteins is regulated by the 
ubiquitin-proteasome system. Ubiquitination is crucial for several 
physiological processes, including cell survival, differentiation, 
innate and adaptive immunity.  
The cellular functions of ubiquitination include proteolytic and 
non-proteolytic roles such as proteasomal degradation of proteins, 
receptor internalization and down regulation, intracellular 
trafficking, inflammatory signaling and assembly or disassembly of 
multi-protein complexes (Grabbe C.  et all 2011). Thus, a wrong 
regulation of ubiquitination might have pathological  
consequences, as degenerative disorders and cancer.  
Ubiquitination is largely mediated by ubiquitin ligases, which 
mark their substrates for, with a series of ubiquitin molecules 
(Hershko et al.  1998). The conjugation of ubiquitin molecules to 
substrates requires coordinated action of the ubiquitin activating 
enzyme (E1), the ubiquitin conjugating enzyme E2 and the E3 
ligase. The E3 ligase enzyme associates with the substrate and 
thereby determines the specificity in degradation or inactivation 
of various substrates (Ciechanover, 1998) (Figure 6).As already 
mentioned, ubiquitination does not always lead to protein 
degradation. Indeed in recent years have been identified more 
than 100 de-ubiquitination enzymes (DUB) that remove ubiquitin 
from substrates, making them available again (Amerik A.Y. et al.  
2004 ;Huang OW et al.  2013)(Figure 6). 
The RING finger ubiquitin E3 ligases contain a characteristic 
cysteine-rich zinc binding domain defined by a pattern of 
conserved cysteine and histidine residues. These ligases efficiently 
catalyze poly-ubiquitination of given substrates (Joazeiro et al.  
2000). Characteristic of RING finger ubiquitin E3 ligases is the 
ability to mediate degradation of their substrates, by promoting 
their own ubiquitin-dependent degradation (Lorick et al.  1999). 
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Figure 6. Schematic representation of ubiquitin system.The conjugation of 
ubiquitin molecules to substrates requires coordinated action of three enzymes: 
the ubiquitin activating enzyme (E1), the ubiquitin conjugating enzyme E2 and 
the E3 ligase, that associates the ubiquitin molecules to the substrates.  Once 
ubiquitinated, the proteins can be degraded by the proteasome or de-
ubiquitinated by a specific DUBs enzyme.   
 
 
1.4 RING ligase Praja2  
Praja2 belongs to the Ring H2 finger E3 ubiquitin ligase 
subfamily. It contains, in fact, at COOH-terminal end (aa 629-678) 
a characteristic sequence domain known as the RING-H2-finger 
motif (Freemont, 1993). The RING-H2-finger motif is similar to the 
RING-finger motif, and Cys4 in the RING-finger motif is replaced by 
His (Freemont, 1993). 
Praja E3 ligase family is composed by two members, namely 
praja1 and praja2, that share high sequence homology. 
praja2 gene is localized on the long arm of human chromosome 5 
(5q21) and its transcript encodes for a protein of 708 amino-acidic 
with an estimate weight of 78 KDa (Nakayama et al.  1995).But 
SDS-polyacrylamide electrophoresis gel show that the molecular 
mass of praja2 is estimated to be about 140 kDa . This discrepancy 
between the expected and observed molecular masses might be 
explained by anomaly of protein migration rates on SDS-
polyacrylamide gel (Ohara and Teraoka, 1987).Instead,praja1 gene 
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mapped on human chromosome X. Northern blot analysis identify 
a 2.7 Kbp ribonucleotide transcript, coding for a protein of  643 
amino-acids, with an estimate  weight of 71 kDa (Ping et al.  2002).  
Praja1 and praja2 show high sequence homology, more or less 
of 52.3% of identity and their COOH terminal domains contain a 
RING H2 Finger domain highly conserved. It is demonstrated that 
in mice, praja1 has an important role in neuronal plasticity that is 
the basis for learning and memory (Ping et al.  2002), in fact praja1 
expression shows learning-specific induction in the basolateral 
complex of the amygdala during formation of fear memory(Stork 
et al.  2001).Structural data and sequence analysis identified in 
praja2 COOH terminal domain (aa 583-600) a particular motif, 
highly conserved among all the praja family members, encoding an 
α-amphipathic helix. This domain is characteristic of AKAPs family 
proteins, and is known to be fundamental for PKA anchoring 
(Figure 7) 
 
 
 
Figure 7. Schematic representation of praja proteins. Praja1 and praja2 are 
composed respectively  by 643 and 708 amminoacids. Both proteins are 
characterized by a RING-H2 motif (in rose) and a putative amphypatic helical 
wheel (in yellow) at COOH-terminal. 
 
Following axotomy, axonal degeneration and neuronal cell 
death correlate with strong down-regulation of praja2 expression 
levels in rat (Nakayama et al.  1995).  Thus, regulating synaptic 
communication and plasticity, praja family proteins play a crucial 
role in neuronal activity and development (Nakayama et al.  
1995). praja2 plays an important role in several molecular 
mechanisms that mostly involve the cAMP-dependent signal 
transduction pathway. First of all, praja2 controls the stability of 
mammalian regulatory subunits of Protein Kinase A settling the 
strength and duration of PKA signal output in response to cAMP, 
so it is required for efficient nuclear cAMP signaling and PKA-
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mediated long-term memory (Lignitto et al. 2011). 
Moreoverpraja2 is involved in cAMP-induced neurite outgrowth, 
promoting proteasomal degradation of NOGO-A, a major inhibitor 
of neurite outgrowth in mammalian brain (Sepe et al. 2014) 
(Figure 8) 
 
 
 
 
Copyright Sepe et al. 2014, Pnas  
Figure 8. Model of praja2–NOGO-A pathway. Under basal conditions, NOGO-A 
inhibits neurite outgrowth. Activation of adenylate cyclase (AC) by BDNF or by 
Forskolin (Fsk) increases cAMP levels and dissociates PKAholoenzyme. Active 
PKA catalytic subunit phosphorylates praja2, which in turn ubiquitinates and 
degrades NOGO-A through the UPS. The drop in NOGO-A levels promotes 
neurite outgrowth(Sepe et al. 2014). 
 
In addition, praja2 has a role in a tumor growth, indeed it 
ubiquitinates and degrades MOB1, a core component of 
NDR/LATS kinase and a positive regulator of the tumor-suppressor 
Hippo cascade. This degradation attenuates the Hippo cascade, 
controls the organ size and sustains glioblastoma growth in vivo 
(Lignitto et al.  2013)(Figure 9). 
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Figure 9.Schematic representation of the role of praja2 in the Hippo pathway. 
Praja2 ubiquitinates MOB1 and degrades it thorugh the proteasome system. 
MOB1 degradation attenuates LATS1/2 kinase activity, preventing 
phosphorylation and inactivation of YAP. Un-phosphorylated YAP accumulates 
in the nucleus and drives gene transcription, promoting cell proliferation and 
tumor growth. 
 
 
On the other hand,praja2 is markedly over-expressed in 
differentiated thyroid cancer, and its levels inversely correlate 
with the malignant phenotype of the tumor (Cantara et al.  2012).  
Finally, praja2 also seems to be involved in the regulation of 
insulin secretion. Indeed, in response to glucose stimulation, 
praja2 ubiquitinates and degrades p35, activating calcium 
signaling and promoting insulin secretion (Sakamaki J. et al. 2014) 
Many RING proteins have functions unknown or unrelated to 
the ubiquitination in evident manner. Interestingly, several RING 
finger genes have been found mutated in human diseases 
(Mattson et al.  2001; Kitada et al.  1998). For instance, the parkin 
gene was found mutated in autosomal recessive familial juvenile 
Parkinsonism (Kitada et al.  1998). 
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AIM OF THE STUDY 
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Kinase Suppressor of Ras 1 (KSR1) is an evolutionally 
conserved protein kinase that plays a fundamental role for 
correct activation, propagation and attenuation of the mitogenic 
pathway (Roskoski et al. 2012). In response to Ras activation, 
KSR1 assembles a kinase complex that optimally transfers signals 
generated at cell membrane to downstream ERK signaling.  
Ubiquitination is a post-translational mechanism that controls 
the activity/stability of a wide array of cellular target proteins. By 
modulating protein stability, the ubiquitin pathway controls key 
physiological processes, such as survival, differentiation and cell 
proliferation (Grabbe C.  et all 2011). 
Our laboratory is involved in the regulation of the ubiquitin 
pathway by the E3 ubiquitin-ligase praja2. Recently, we 
identifiedpraja2 as a component of the complex assembled by 
KSR1. During the PhD program, my principal aim was to 
understand if KSR1 and praja2 formed a complex in living cells and 
how the complex regulates MAPK signaling. More specifically, I 
focused my attention on the following issues: 
 
 Verify the existence of KSR1-praja2 complex in living cells.  
 Test if praja2 ubiquitinates KSR1in vitro and in vivo.  
 Define the functional relevance of praja2 in KSR1-dependent 
mitogenic pathway. 
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RESULTS 
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2.1 praja2 and KSR1 form a stable complex  
To gain insights into praja2 action, I tested if praja2 interacts 
with protein/adaptors involved in mitogenic signaling. To this end, 
I performed co-immunoprecipitation assays using antibodies 
directed against distinct components of the ERK pathway. This 
analysis allowed the identification of Kinase Suppressor of Ras 1 
(KSR1) as a relevant interactor of praja2. A proteomic screening 
previously identified praja2 as component of a macromolecular 
complex that includes KSR1(Dougherty M.K. et al. 2009). 
First, I investigated whether endogenous praja2 and KSR1 interact 
in cells. Lysates from HEK293 cells were immunoprecipitated with 
anti-praja2 or with non-immune IgG. Precipitates were 
immunoblotted with anti-KSR1 and anti-praja2 polyclonal 
antibody. As shown, an endogenous praja2-KSR1 complex could 
be detected (Figure 10). 
 
 
 
 
Figure 10. praja2 binds KSR1. Lysates (2mg) from HEK293 cells were 
immunoprecipitated with anti-praja2or non-immune IgG. Precipitates 
were immunoblotted with anti-KSR1or anti-praja2 polyclonal antibody. 
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2.2  praja2 directly interacts with KSR1 
As shown before, praja2 interacts with KSR1 protein. To 
demonstrate whether this binding is direct, I performed a pull 
down assay using recombinant proteins. Thus, a fusion protein 
carrying the full-length praja2, appended to the C-terminus of 
glutathione S-transferase polypeptide (GST), pulled down in vitro 
translated 35S-labeled KSR1 (Figure 11) 
 
 
 
 
Figure 11. praja2 directly interacts with KSR1 in vitro.In vitro translated, 35S-
labeled KSR1 was subjected to pull-down assays with purified GST or GST-praja2 
fusions.  
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2.3 praja2-KSR1 binding is regulated by serum 
Next, I assessed whether praja2-KSR1 interaction is regulated 
by serum. Lysates from growing or serum-deprived HEK293 cells 
were immunoprecipitated with anti-praja2 or non-immune IgG. 
Precipitates were immunoblotted with anti-KSR1 or anti-praja2 
polyclonal antibody. As shown in Figure 12, the praja2-KSR1 
interaction is regulated by serum. Indeed, praja2-KSR1 complex 
was more evident when cells have been grown in the presence of 
serum. 
 
 
Figure 12.praja2-KSR1 binding is regulated by serum. Lysates (2mg) from 
growing or serum-deprived (18h)HEK293 cells were immunoprecipitated with 
anti-praja2or non-immune IgG. Precipitates were immunoblotted with anti-
KSR1or anti-praja2 polyclonal antibody. 
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2.4  Endogenous KSR1 and praja2 co-localize in Human 
Embryonic Kidney 293 cells. 
Next, to demonstrate that KSR1 and praja2 are located 
within the same cell compartment, I analyzed the localization of 
both proteins in Human Embryonic Kidney 293 cells (HEK293). To 
this end, I performed double immunofluorescence using anti- 
KSR1 and anti-praja2 antibodies. As suspected, the results indicate 
that both proteins have a partial co-localization within the 
cytoplasm and at the perinuclear region, as confirmed by the 
Pearson’s statistic analysis (Figure 13). 
 
 
Figure 13. praja2 and KSR1 co-localize in Human Embryonic Kidney (HEK) 293 
cells.HEK293 cells were subjected to double immunostaining with anti-ksr1 and 
anti-praja2 antibodies. Images were collected and analyzed by confocal 
microscopy. Magnification of selected areas is shown (insets). Co-localization 
Pearson’s coefficient praja2-KSR1~0.54. Scale bar: 10 m. 
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2.5  Mapping the praja2 binding domain on KSR1. 
The data above demonstrate thatKSR1 and praja2 form a stable 
complex in lysates and partly co-localize within the same sub-
cellular compartment. To determine whether praja2 ligase activity 
is required for KSR1 binding, HEK293 cells were transiently 
transfected with flag-tagged praja2 or with a flag-tagged 
praja2RING mutant. The mutant protein carries cysteine to alanine 
substitutions within the RING domain (cys634 and cys671) 
(praja2rm) that interferes with the transfer of the ubiquitin moiety 
from E2 to the substrate. Lysates were immunoprecipitated with 
anti-flagantibody. Results show that praja2 ligase activity was not 
necessary for KSR1 binding, since praja2rm binds KSR1 as wild type 
protein. To identify the domain of praja2 that mediates the 
binding to KSR1, I generated a series of deletion mutants lacking 
distinct segments of praja2. Flag-tagged praja2 mutants were co-
expressed with KSR1 in HEK293 cells. Lysates were 
immunoprecipitated with anti-KSR1 antibody, and immunoblotted 
with anti-flag antibody.  
The results show that the mutant lacking aminoacids from 402 
to 708 was not able to bind KSR1, suggesting that residues 402 to 
531 of praja2 are most likely required for optimal binding to KSR1 
(Figure 14). 
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Figure 14. praja2 402-531 residues mediate the binding to KSR1. Schematic 
representation of human praja2 and its deletion mutants. RING domain and 
KSR1 binding domain are shown in grey and in blue (upper panel), respectively. 
HEK293 were transfected with flag-praja2, praja2 RING mutant (C634,671A; 
praja2rm), or with each of the three deletion mutants (Δ631-708,Δ531-708, 
Δ402-708). Cells were treated with MG132 (10 μM) for 6 hours before 
harvesting. Lysates were immunoprecipitated (IP) with anti-KSR1 and 
immunoblotted with anti-Flag and anti-KSR1 antibodies. 
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2.6  Mapping the KSR1 binding domain on praja2 
 
Next, I analyzed which part of KSR1 interacts with praja2. To this 
end, overlapping 25-mer peptides derived from human KSR1 were 
spotted onto a membrane and overlaid with purified GST-
praja2431-531 fusion protein, as previously described (Stefan E. et al. 
2011). I identified one binding motif at the C-terminus of KSR1 
(DLQEROSFSL) as the core region required for praja2 binding 
(Figure15A). As expected, a recombinant protein carrying the core 
peptide of KSR1 fused at the C-terminus of the GST polypeptide 
was sufficient in binding flag-praja2 in vitro (Figure15B). The 
peptide is located at the surface of the predicted KSR1 structure, 
supporting the findings of a direct interaction with praja2 
(Figure15C).  
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Figure 15. KSR1 necessary binding site for praja2 is on the surface of protein. 
(A) Spotted peptides (25 mer, 15 amino-acids overlap) of KSR1 were overlaid 
with recombinant GST-praja21-531 followed by immunoblotting with anti-GST. 
The potential binding amino acids are shown in red (upper panel).(B)HEK293 
were trasfected with flag-praja2 and the lysates were incubated over night with 
GST fusion protein containg a peptide sequence (GST-pep) and a scramble short 
sequence (GST-cnt). The proteins were immunoblotted with anti-Flag and anti-
GST antibodies.(C)KSR1 predicted structure (down panel).The potential praja2 
binding site is shown in red.  
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2.7 praja2 ubiquitinates KSR1 
E3 ubiquitin ligase praja2 binds KSR1. Therefore, I tested if 
praja2 acting as E3 ligase ubiquitinates KSR1. HEK293 cells were 
co-transfected with praja2-flag, praja2rm-flag, and HA-ubiquitin 
vectors. Lysates were immunoprecipitated with anti−KSR1 
antibody. The precipitates were  immunoblotted with anti-HA, 
anti-KSR1 and anti-flag antibodies. The data indicates that 
expression of praja2, but not of praja2rm, induced accumulation 
of poly-ubiquitinated KSR1 molecules (Figure 16A). Next,I 
analysed if the activation of tyrosine kinase receptor (RTK) 
modulates KSR1 ubiquitination. Stimulation by epidermal growth 
factor (EGF) induced a strong KSR1 
polyubiquitination(Figure16B). Expression of praja2rm 
dramatically impaired ubiquitination of KSR1 induced by EGF 
(Figure 16C). An in vitro ubiquitination assay demonstrated that 
KSR1 is, indeed, a direct substrate of praja2 (Figure 16D).  
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Figure 16.praja2 ubiquitinatesKSR1. (A) HEK293 cells were co-transfected with 
HA-ubiquitin, and praja2 or praja2rm. After 24 hours cells were harvested and 
the lysates were immunoprecipitated with anti−KSR1 and immunobloƩed with 
anti-HA, anti-KSR1 and anti-flag antibodies. (B) HEK293 cells were transfected 
with HA-tagged ubiquitin.  24 hours after transfection, cells were either left 
untreated or stimulated with EGF (100ng/ml) at indicated time. Lysates were 
immunoprecipitated with anti-KSR1 and immunoblotted with anti-HA, anti-KSR1  
antibodies. (C)HEK293  were co-transfected as in Figure(A) and stimulated at 
indicated time with EGF.(D) In vitro translated, 35S-labeled KSR1 was incubated 
with his6-tagged ubiquitin, in the presence or absence of E1, UbcH5c (E2) and 
anti-flag precipitates from HEK293 extract transiently transfected with praja2-
flag, praja2rm. The reaction mixture was denatured, size-fractionated on 7% 
SDS-PAGE, and analyzed by autoradiography. A fraction of the reaction mixture 
was immunoblotted with anti-flag antibody (lower panel). 
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2.8 praja2 controls ERK1/2 signaling  
The findings indicate that KSR1 in response to receptor 
activation becomes a relevant target of the ubiquitin pathway. 
Given the relevant role of KSR1 in ERK1/2 signalling, we 
investigated if praja2 modulates RTK-dependent ERK cascade. To 
this end, we monitored ERK1/2 phosphorylation at its active site 
(Thr202/Tyr204)in cells stimulated with EGF. As shown in Figures 
17Aand 17B, in control cells, EGF treatment induced ERK1/2 
phosphorylation overtime from stimulation. Expression of 
praja2rmincreased both basal and EGF-induced ERK 
phosphorylation, by several fold over control values. Furthermore, 
genetic knockdown of endogenous praja2 also sustained ERK1/2 
phosphorylation, compared to controls (Figure17C).  
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Figure 17: praja2 control ERK1\2 signaling. (A) HEK293 or U2OS (B) cells were 
transfected with CMV or Flag-rm. 24 hours after transfection, cells were treated 
EGF (100ng\ml) for indicate times . Lysates were separated on SDS-page and 
immunoblotted with anti p-ERK antibody. Anti-flag antibody is used as 
transfection control and anti-ERK2 asloading control. (C) HEK293 cells were 
transfected with control siRNA or praja2 siRNA. Than they are processed as 
above.(D).Cumulative data of the experiment shown in A&B.Data are expressed 
as a mean value ± S.E.M of three independent experiments. 
  
D 
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Next, we explored the functional relevance of the praja2 binding 
to KSR1 in ERK signalling. Cells were pre-treated for 6h with a 
stearated synthetic peptide spanning the praja2 binding motif of 
KSR1 (KRS1pep-flag) or with a flag-tagged scrambled peptide 
(CNTpep-flag). As shown in Figure 18, both peptides efficiently 
accumulated within the treated cells. The cells were then 
stimulated with EGF. ERK phosphorylation was monitored over a 
time-point curve. As shown in Figures 19, pre-treatment with 
KSR1pep-flag enhanced both, basal and EGF-induced ERK 
phosphorylation. The effects of KSR1pep on ERK signalling were 
replicated in other cell lines (HEK293 and U-87 MG), suggesting a 
more general role of praja2 in the control of KSR1 pathway. 
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Figure 18. The synthetic peptides accumulate efficiently within the cell. 
HEK293 cells were treated for 8 hours with a stearated synthetic peptide 
containing a Flag-tag spanning the praja2 binding motif ofKSR1 (Ksr1pep-flag) or 
with a flag-tagged scrambled peptide (CNTpep-flag). After cells are subjected to 
immunostaining with monoclonal anti-flag. Images were collected and analyzed 
by confocal microscopy. DRAQ5 staining for nuclei detection was used (blu). 
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Figure 19: the binding between praja2 and KSR1 is fundamental for ERK1\2 
signalling. U2OS cells were pre-trated withCNTpep-flag orKsr1pep-flag 
.aftercells were treated with EGF (100ng\ml) for indicate times. Lysates were 
separated on SDS-page and immunoblotted with anti p-ERK antibody. Anti-flag 
antibody is used as transfection control and anti- ERK2 asloading 
control.(B)Cumulative data of the experiment shown in (A).Data are expressed 
as a mean value ± S.E.M of four independent experiments. 
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Here, I report for the first time a new regulatory mechanism 
of KSR1scaffold through ubiquitination. I found that, in course 
ofgrowth factors stimulation, KSR1 undergoes to rapid poly-
ubiquitination, which eventually leads to attenuation of the ERK 
pathway. Ubiquitination of KSR1 was induced by EGF. I identified 
praja2 as the principal E3 ligase responsible of KSR1 
ubiquitination. 
Signals originated at cell membrane are efficiently 
transmitted to downstream effectors and rapidly attenuated, 
eventually leading to resensitization of the pathway. The 
intricate interplay between ON/OFF state of the signaling 
pathway gives rise to signaling waves that rapidly propagate 
throughout the cell, eliciting biological responses that strictly 
depend on the intensity and frequency of the oscillatory circuits. 
In this context KSR1 plays a key role as scaffold protein 
involved in the propagation and regulation of the mitogenic 
pathway of MAP kinases. 
KSR1 contribution to the regulation of the MAPK signaling is 
finely tuned because of anauto-regulatory series of 
phosphorylation/dephosphorylation events on KSR1. 
Indeed, phosphorylation on KSR1 byC-TAK1, in resting 
condition, keeps the scaffold inactive, until a growth stimulus 
activates PP2A(Muller j. et al.  2001;  Roy F. et al. 2002;  Ory S. et 
al. 2003).Dephosphorylation of KSR1 by PP2A activates the 
protein that, in turn, amplifies the MAPK cascade. When the 
signaling has to be turned off, activated ERK1/2 phosphorylates 
another site on KSR1, causing the disassembly of the multikinase 
complex and regulating the temporal duration of the signal. 
(McKay et al. 2009). 
The principal mechanism regulating KSR1 activity wasmostly 
based on phosphorylation. A variety of attenuation mechanisms  
have been identified, so far (Alexander Y. et al. 2008 ; Sandra 
L Harris and Arnold J Levine  2005 ; Errede B. 1996;Dhillon AS. 
2007). In the case of ERK pathway, a negative loop between ERK 
and KSR1 complex ensures acycle of activation/de-activation 
process that limits uncontrolled mitogenic signaling. 
Phosphorylation of KSR1 and B-Raf by locally activated ERK 
dissociates theKSR1 multi-kinase complex, turning-off theERK 
pathway (McKay et al.  2009 ). Bi-directional regulation of KSR1 
and ERK activity controls the rate, the magnitudo and the 
persistence of downstream mitogenic pathways. 
My work added a novel twist in the ERK cascade, identifying 
KSR1 as a target of the ubiquitin pathway and further exploring 
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the regulation of MAPK signal amplitude. 
 Ubiquitination of KSR1 was rapidly induced by EGF pathway, 
indicating that there is an even more tight step of regulation 
between the activation of KSR1 and the inactivation and 
disassembly of the complex. This paralleled downregulation of 
ERK1/2 cascade. Interference of praja2 expression/activity or 
expression of a praja2 mutant carrying mutations within H2-RING 
domain sites, negatively impacted on KSR1 ubiquitination, 
enhancing ERK activation and prolonging the wave of 
downstream signaling. A peptide targeting the praja2 binding 
interface on KSR1 by preventing Praja2 binding to KSR1 and 
consequent ubiquitination of the scaffold increased both, basal 
and ligand-induced ERK phosphorylation. These findings further 
support the role of praja2 in the negative regulation of KSR1 
signaling.  
 Hence, praja2 acts in response to EGF stimulation in 
promoting KSR1 ubiquitination and ERK attenuation, pointing to 
a more general role of praja2 in controlling of the strength and 
duration of KSR1-ERK cascade (Figure 20). 
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Figure 20. praja2-KSR model. Stimulation of receptors by a ligand that activates 
KSR1/2, which in turn induce sequential activation of mitogenic kinases (ON). 
Recruitment of praja2 within the multi-kinase scaffold induces poly-
ubiquitination of KSR, and consequent attenuation of the ERK pathway (OFF). 
 
 
In conclusion, the findings highlight the importance of the 
praja2-mediated ubiquitination of KSR1 in the control of mitogenic 
signaling. Exploring further the mechanism(s) regulating 
ubiquitination of KSR1 in course of growth factor stimulation, and 
identifying additional praja2 targets in the ERK1/2 cascade will 
provide essential tools to dissect and manipulate these important 
signaling pathways. 
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Cell lines. Human embryonic kidney cell line (HEK293), 
glioblastoma cells (U87MG) and osteosarcoma cells (U2OS) were 
cultured in Dulbecco modified Eagle’s medium containing 10% 
fetal bovine serum in an atmosphere of 5% CO2 
Plasmids and transfection. Vectors encoding the flag-praja2 
and GSTpraja2 were purchased from Genecopeia. praja2rm was 
generated by site-directed mutagenesis, while praja2 deletion 
mutants and GST-fusions were generated by PCR with specific 
oligonucleotide primers. PCR products were sub-cloned into the 
same vector of wild-type praja2cDNA. HA-tagged ubiquitin was 
provided by Dr Antonio Leonardi (University of Naples, Italy); flag-
tagged KSR  vectors was provided  by Addgene Vector 
Database.GST-fusion peptides were generated by Eduard Stefan 
(University of Innsbruck);SMART pool siRNAs targeting coding 
regions were purchased from Dharmacon. The following are the 
siRNA sequences (Thermo Scientific) targeting human praja2: 
sequence 1: 5′GAAGCACCCUAAACCUUGA-3′ ; 
Sequence2:5′AGACUGCUCUGGCCCAUUU-3′; 
sequence 3: 5′-GCAGGAGGGUAUCAGACAA-3′;  
sequence 4: 5′-GUUAGAUUCUGUACCAUUA-3′.  
The siRNAs were transiently transfected using Lipofectamine 2000 
(Invitrogen) at a final concentration of 100 pmol/ml of culture 
medium. 
Antibodies and chemicals. Rabbit polyclonal antibodies 
directed against KSR1 (immunoblot dilution 1:1000, 
immunostaining dilution 1:100) and Phospho44/42 MAPK (P-
ERK1/2)(immunoblot dilution 1:1000) were bought from Cell 
Signaling; ERK2(immunoblot dilution 1:8000) and glutathione S-
transferase (GST)(immunoblot dilution 1:8000)  from Santa Cruz; 
α−tubulin (immunoblot dilution 1:8000), flag (immunoblot dilution 
1:4000, immunostaining dilution 1:400, immunoprecipitation 
dilution 1:200 )  and myc epitope (immunoblot dilution 1:1000) 
from Sigma; hemaglutinin epitope (immunoblot dilution 1:1000) 
(HA.11) from Covance; Rabbit polyclonal antibodies directed 
against praja2 (immunoblot dilution 
1:1000,immunostainingdiluition 1:400) was purchased from 
Bethyl. Fluorescein- or rhodamine-tagged anti-rabbit and anti-
mouse IgG secondary antibodies were purchased from 
Technogenetics.EGF (used 100ng/ml) were purchased from Sigma. 
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Western Blot Analysis.Cells were washed twice with 
phosphate-buffered saline and lysed in saline buffer-1% Triton-X 
100 (NaCl, 150 mM; Tris-HCl, 50 mM, pH8; EDTA, 5 mM) or, for 
immunoprecipitation assay, in saline buffer 0.5% NP40 (50mMTris-
HCl, pH 7.4, 0.15MNaCl, 100 mM EDTA,0.5% NP40) containing 
aprotinin (5 μg/ml), leupeptin (10 μg/ml), pepstatin (2 μg/ml), 0.5 
mM PMSF, 2 mM orthovanadate, and 10 mM NaF.The lysates 
were cleared by centrifugation at 15,000 g for 10 min. An aliquote 
of whole cell lysate (WHL) (100 μg) were resolved on sodium 
dodecyl sulfate polyacrylamide gel (SDS-PAGE) and transferred on 
nitrocellulose membrane (Biorad, Milan, Italy) for 3 h. Filters were 
blocked for 1 h at room temperature in Tween-20 Phosphate 
buffer saline (TPBS) (PBS- Sigma, 0,1% Tween 20, pH 7.4) 
containing 5% non-fat dry milk. Blots were then incubated O/N 
with primary antibody. Blots were washed three times with TPBS 
buffer and then incubated for 1 h with secondary antibody 
(peroxidase-coupled anti-rabbit (GE-Healthcare) in TPBS. Reactive 
signals were revealed by enhanced ECL Western Blotting analysis 
system (Roche). 
Immunoprecipitation and pull-down assay.Cells were 
homogenized inlysis buffer described above.Cell lysates (1.5 mg) 
were immunoprecipitated with the indicated antibodies. An 
aliquot of cell lysate (100 g) or immunoprecipitated were 
resolved by SDS-PAGE gel and transferred to Protran membrane. 
The immunoblot analysis was performed as previously 
described.GST fusions were expressed and purified from BL21 
(DE3) pLysS cells. 20 μl of GST or GST-praja2 beads were incubated 
with 2 mg of cell lysate or with in vitro translated [35S]-labeled 
KSR1 in 200 μllysis buffer (150 mMNaCl, 50 mMTris-HCl pH 7.5, 1 
mM EDTA, 0.5% triton X-100) in rotation at 4 °C overnight. Pellets 
were washed four times in lysis buffer supplemented with NaCl 
(0.4 M final concentration) and eluted in Laemmli buffer. Eluted 
samples were resolved on8%-SDS PAGE gel, transferred to 
nitrocellulose membranes and immunoblotted with the indicated 
antibody. Pull down between GST-control peptide or GST-KSR1 
peptide and overexpressed flag-praja2cells was performed as 
described above. 
In vitro ubiquitination assay.[35S]-labeled KSR1was synthesized 
in vitro using TnT quick coupled transcription/translation system 
(Promega) in the presence of 45μCi of [35S]-labeled methionine. 
The ubiquitination assay was performed in buffer containing 50 
mM Tri-HCl pH 7.5, 0.6 Mmdithiothreitol, 5mM MgCl2, 
supplemented with recombinant his-ubiquitin (2.5 μg/μl), 2 mM 
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ATP, E1 (1.5 ng/μl) (Affinity Research, Exeter, UK), purified E2 (10 
ng/μl) (UbcH5b) in the presence or absence of agarose beads-
bound praja2-flag or its mutants immunoprecipitated from cell 
lysates. The reaction mixture was incubated at 30oC for 90 min, 
then stopped with Laemmli buffer and resolved on 8% SDS-PAGE. 
Ubiquitination products were visualized by autoradiography.  
Confocal microscopy and image analysis. Cells were plated on 
poly-L-lysine (10µg/ml) coated glass cover slips. Growing or 
peptides-treated cells were rinsed with PBS and fixed in 3% 
paraformaldehyde for 20 min. After permeabilization with 0.5% 
Triton X-100 in PBS for 5 min, the cells were incubated with 1× 
PBS, 0.1 mg/ml bovine serum albumin for 60 min at room 
temperature. Double immunofluorescence was carried out with 
the following antibodies: anti-praja2 (1:400) and anti-KSR1 (1:100) 
or flag-tag (1:400) antibodies. Fluorescein- or rhodamine-tagged 
anti-rabbit and anti-mouse IgG (Technogenetics) secondary 
antibodies were used.. Immunofluorescence was visualized using a 
Zeiss LSM 510 Meta argon/krypton laser scanning confocal 
microscope. Quantification of the immunofluorescent images and 
correlation (Pearson's) coefficient were calculated by Image-J 
software. 
KSR1-Peptides treatment. Growing or, were described, serum-
deprived cells were treated with 1 µM of scramble peptide (cnt-
pep) or KSR-peptide (KSR-pep) for 9 hours before stimulation. 
The following are the peptides sequences:  
scramble peptide (cnt-pep) = 
stearic group-FLQWADESRPSFLLMDYDKDDDKD 
KSR1 peptide (KSR-pep)= 
stearic group-WAFDLQERPSFSLLMDDYKDDDDK 
Statistics. All data are presented as mean ± SEM and “n” 
indicates the number of slices. Statistical significance was 
evaluated by unpaired Student's t test. Statistical significance was 
set at p < 0.05. 
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